Literature DB >> 20171513

Radiation dose-volume effects in the brain.

Yaacov Richard Lawrence1, X Allen Li, Issam el Naqa, Carol A Hahn, Lawrence B Marks, Thomas E Merchant, Adam P Dicker.   

Abstract

We have reviewed the published data regarding radiotherapy (RT)-induced brain injury. Radiation necrosis appears a median of 1-2 years after RT; however, cognitive decline develops over many years. The incidence and severity is dose and volume dependent and can also be increased by chemotherapy, age, diabetes, and spatial factors. For fractionated RT with a fraction size of <2.5 Gy, an incidence of radiation necrosis of 5% and 10% is predicted to occur at a biologically effective dose of 120 Gy (range, 100-140) and 150 Gy (range, 140-170), respectively. For twice-daily fractionation, a steep increase in toxicity appears to occur when the biologically effective dose is >80 Gy. For large fraction sizes (>or=2.5 Gy), the incidence and severity of toxicity is unpredictable. For single fraction radiosurgery, a clear correlation has been demonstrated between the target size and the risk of adverse events. Substantial variation among different centers' reported outcomes have prevented us from making toxicity-risk predictions. Cognitive dysfunction in children is largely seen for whole brain doses of >or=18 Gy. No substantial evidence has shown that RT induces irreversible cognitive decline in adults within 4 years of RT. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171513      PMCID: PMC3554255          DOI: 10.1016/j.ijrobp.2009.02.091

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  67 in total

1.  Dose conformity of gamma knife radiosurgery and risk factors for complications.

Authors:  J L Nakamura; L J Verhey; V Smith; P L Petti; K R Lamborn; D A Larson; W M Wara; M W McDermott; P K Sneed
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-12-01       Impact factor: 7.038

2.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Authors:  E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

3.  Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.

Authors:  L S Chin; L Ma; S DiBiase
Journal:  J Neurosurg       Date:  2001-06       Impact factor: 5.115

4.  Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients.

Authors:  O Surma-aho; M Niemelä; J Vilkki; M Kouri; A Brander; O Salonen; A Paetau; M Kallio; J Pyykkönen ; J Jääskeläinen
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

5.  Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.

Authors:  Jing Li; Soren M Bentzen; Markus Renschler; Minesh P Mehta
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

6.  Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.

Authors:  Y M Jen; W L Hsu; C Y Chen; J M Hwang; L P Chang; Y S Lin; W F Su; C M Chen; D W Liu; H L Chao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

Review 7.  Neurologic sequelae of treatment of primary CNS lymphomas.

Authors:  U Schlegel; H Pels; R Oehring; I Blümcke
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

8.  Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.

Authors:  M Fuss; F Wenz; R Scholdei; M Essig; J Debus; M V Knopp; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

9.  Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.

Authors:  Gaurav D Shah; Joachim Yahalom; Denise D Correa; Rose K Lai; Jeffrey J Raizer; David Schiff; Renato LaRocca; Barbara Grant; Lisa M DeAngelis; Lauren E Abrey
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

10.  Early radiotherapy dose response and lack of hypersensitivity effect in normal brain tissue: a sequential dynamic susceptibility imaging study of cerebral perfusion.

Authors:  S J Price; R Jena; H A L Green; N F Kirkby; A G Lynch; C E Coles; J D Pickard; J H Gillard; N G Burnet
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-07-13       Impact factor: 4.126

View more
  221 in total

1.  Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.

Authors:  Kazuhiro Ohtakara; Shinya Hayashi; Noriyuki Nakayama; Naoyuki Ohe; Hirohito Yano; Toru Iwama; Hiroaki Hoshi
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

2.  Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning.

Authors:  T Long; M Matuszak; M Feng; B A Fraass; R K Ten Haken; H E Romeijn
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

3.  RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma.

Authors:  Arabinda Das; Daniel G McDonald; Yaenette N Dixon-Mah; Dustin J Jacqmin; Vikram N Samant; William A Vandergrift; Scott M Lindhorst; David Cachia; Abhay K Varma; Kenneth N Vanek; Naren L Banik; Joseph M Jenrette; Jeffery J Raizer; Pierre Giglio; Sunil J Patel
Journal:  Tumour Biol       Date:  2015-12-18

Review 4.  Treatment of pediatric cerebral radiation necrosis: a systematic review.

Authors:  N Drezner; K K Hardy; E Wells; G Vezina; C Y Ho; R J Packer; E I Hwang
Journal:  J Neurooncol       Date:  2016-07-20       Impact factor: 4.130

5.  Total target volume is a better predictor of whole brain dose from gamma stereotactic radiosurgery than the number, shape, or location of the lesions.

Authors:  Ganesh Narayanasamy; Adam Smith; Emily Van Meter; Ronald McGarry; Janelle A Molloy
Journal:  Med Phys       Date:  2013-09       Impact factor: 4.071

6.  Double-strand breaks on F98 glioma rat cells induced by minibeam and broad-beam synchrotron radiation therapy.

Authors:  S Gil; Y Prezado; M Sabés
Journal:  Clin Transl Oncol       Date:  2013-11-23       Impact factor: 3.405

7.  Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.

Authors:  J Sherriff; J Tamangani; L Senthil; G Cruickshank; D Spooner; B Jones; C Brookes; P Sanghera
Journal:  Br J Radiol       Date:  2013-02       Impact factor: 3.039

8.  Response-driven imaging biomarkers for predicting radiation necrosis of the brain.

Authors:  Mohammad-Reza Nazem-Zadeh; Christopher H Chapman; Thomas Chenevert; Theodore S Lawrence; Randall K Ten Haken; Christina I Tsien; Yue Cao
Journal:  Phys Med Biol       Date:  2014-04-28       Impact factor: 3.609

9.  Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.

Authors:  Michael Lundemann; Per Munck Af Rosenschöld; Aida Muhic; Vibeke A Larsen; Hans S Poulsen; Svend-Aage Engelholm; Flemming L Andersen; Andreas Kjær; Henrik B W Larsson; Ian Law; Adam E Hansen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-02       Impact factor: 9.236

10.  Clinical Evaluation of Shot-Within-Shot Optimization for Gamma Knife Radiosurgery Planning and Delivery.

Authors:  Perry B Johnson; Maria I Monterroso; Fei Yang; Elizabeth Bossart; Amir Keyvanloo; Eric A Mellon
Journal:  World Neurosurg       Date:  2018-11-24       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.